PRTA - Alzheimer's drug developers get lift from Anavex results
2023-09-14 13:02:36 ET
More on Alzheimer's drug developers
- Cassava Sciences: Insiders Purchasing Stock, Is The Market Still Buying Simufilam?
- Prothena: Dunn Appointment And Bristol Opt-In Boost Validation
- Anavex Life Sciences: Multiple CNS Shots On Goal Awaiting Convincing Data
- Anavex: Will Be An Interesting Endgame To Watch
- Cassava Sciences: CMS Data Promising But Many Red Flags Remain; Hold
- Anavex Alzheimer's candidate slows cognitive decline in key study
For further details see:
Alzheimer's drug developers get lift from Anavex results